Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2009
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/10/2009US7501392 Method of treatment of viral hepatitis C with interferon alpha 5
03/10/2009US7501260 Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment
03/10/2009US7501125 Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent
03/10/2009CA2598719A1 Method for inducing defective nef gene in hiv-1 using red ginseng
03/10/2009CA2501584C The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
03/10/2009CA2415068C Oral compositions comprising antimicrobial agents
03/05/2009WO2009029831A1 Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
03/05/2009WO2009029686A1 Immunogenic compositions and methods
03/05/2009WO2009029384A2 Compounds for the treatment of hepatitis c
03/05/2009WO2009029132A2 Antigen-binding proteins targeting s. aureus orf0657n
03/05/2009WO2009028972A1 A new inhibitor of dd-peptidase and its use as antibiotic or anticancer drug
03/05/2009WO2009028573A1 Use of ribavirin in blood coagulation disorder
03/05/2009WO2009028495A1 Agent for fungal dermatitis
03/05/2009WO2009027753A1 Composition and method inhibiting inflammation
03/05/2009WO2009027733A1 (2-pyridin-3-ylimidazo[1,2-b]pyridazin-6-yl) urea derivatives as antibacterial agents
03/05/2009WO2009027732A1 5-6-bicyclic heteroaromatic compounds with antibacterial activity
03/05/2009WO2009027730A1 Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009WO2009027634A1 Antiseptics
03/05/2009WO2009027473A1 Combinations of imazalil and hydroxypyridones
03/05/2009WO2009027470A1 LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
03/05/2009WO2009027057A1 Antiviral composition comprising a sulfated polysaccharide
03/05/2009WO2009026790A1 Crystal entecavir fomulation and the preparation method thereof
03/05/2009WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids
03/05/2009WO2009010479A3 Heterocyclic methylene piperidine derivatives and their use
03/05/2009WO2009010477A8 Piperidine-4-acetic acid derivatives and their use
03/05/2009WO2009008905A4 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
03/05/2009WO2009003090A9 Compositions and methods for inhibiting viral and bacterial activity
03/05/2009WO2009000824A3 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
03/05/2009WO2008148754A3 Macrocycles and their uses
03/05/2009WO2008147557A3 Heteroaryl substituted thiazoles and their use as antiviral agents
03/05/2009WO2008131502A3 Antiviral compounds of the adamantane type
03/05/2009WO2008127274A3 Heterocyclic inhibitors of bacterial peptidyl trna hydrolase and uses thereof
03/05/2009WO2008092826A3 Cistus extracts
03/05/2009WO2008070447A3 Anti-viral compounds
03/05/2009WO2005121138A3 Heterotricyclic compounds for use as hcv inhibitors
03/05/2009US20090062401 Decaline-derived compounds as pharmaceutically active agents
03/05/2009US20090062391 Use of a virucidal ointment in the nares for prevention of transmission and contraction of common colds
03/05/2009US20090062378 Nutraceutical Mangosteen Composition
03/05/2009US20090062362 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System
03/05/2009US20090062357 Deuterium-enriched fluconazole
03/05/2009US20090062348 Antifungal Agent Containing Pyridine Derivative
03/05/2009US20090062346 Deuterium-enriched tipranavir
03/05/2009US20090062337 Treatment of Microbial Infections
03/05/2009US20090062331 Deuterium-enriched maraviroc
03/05/2009US20090062315 Pharmaceutical Acceptable Composition Containing Non-Steroidal Anti-Inflammatory Drug and Local Anesthetics
03/05/2009US20090062314 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
03/05/2009US20090062311 Macrocylic inhibitors of hepatitis c virus
03/05/2009US20090062310 Deuterium-enriched voriconazole
03/05/2009US20090062294 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
03/05/2009US20090062283 Deuterium-enriched linezolid
03/05/2009US20090062278 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
03/05/2009US20090062272 Imidazoquinolinyl sulfonamides
03/05/2009US20090062268 Novel inhibitors of poly(adp-ribose)polymerase (parp)
03/05/2009US20090062266 7-methoxy-2-methyl-N-[[(5S)-[3-[3-fluoro-4-(piperazin-1-yl)phenyl]-2-oxo-5-oxazolidinylmethyl]-3-quinolinecarboxamide, useful for the treatment of grampositive and some gramnegative bacterial infections, with a weak monoamine oxidase inhibitory activity
03/05/2009US20090062263 4-Hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
03/05/2009US20090062255 Tumor-targeting evaluation methodology and compounds related thereto
03/05/2009US20090062250 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
03/05/2009US20090062237 Evaluating immune competence
03/05/2009US20090062234 Substituted organopolysiloxanes and use thereof
03/05/2009US20090062223 Amino tricyclic-nucleoside compounds, compositions, and methods of use
03/05/2009US20090062220 Deuterium-enriched azithromycin
03/05/2009US20090062218 Macrolone compounds
03/05/2009US20090062214 Left-Side Glucose Lipid a Analogue
03/05/2009US20090062190 Transcriptional Regulation of Cytokines by LITAF and STAT (6)(B)
03/05/2009US20090062189 Tumor suppressor protein and nucleotide encoding same
03/05/2009US20090062185 Deuterium-enriched anidulafungin
03/05/2009US20090062182 Deuterium-enriched dalbavancin
03/05/2009US20090061031 Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus
03/05/2009US20090061027 Composition For The Prevention and Treatment Of Common Cold Diseases
03/05/2009US20090061009 Composition and Method of Treatment of Bacterial Infections
03/05/2009US20090060994 Controlled release azithromycin solid dosages forms
03/05/2009US20090060954 Recombinant BCG Vaccine
03/05/2009US20090060952 Production of the lipidated form of the peptidoglycan-associated liproproteins of gram-negative bacteria
03/05/2009US20090060950 Method for Producing Viral Vaccines
03/05/2009US20090060948 Cationic lipid-mediated enhancement of nucleic acid immunization of cats
03/05/2009US20090060946 Activation of antigen-specific T cells by virus/antigen-treated dendritic cells
03/05/2009US20090060945 Integration of meningococcal conjugate vaccination
03/05/2009US20090060941 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols
03/05/2009US20090060937 Immunostimulatory oligonucleotides and uses thereof
03/05/2009US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence
03/05/2009US20090060921 Glycan-optimized anti-cd20 antibodies
03/05/2009US20090060915 Polypeptide, vaccine and use thereof
03/05/2009US20090060913 Combination therapy with type i and type ii anti-cd20 antibodies
03/05/2009US20090060911 Enhancement of antibody-mediated immune responses
03/05/2009US20090060908 antibodies exhibit increased antibody-dependent cellular cytotoxicity activity; humanizing, chimera
03/05/2009US20090060904 Vegetarian Protein A Preparation and Methods Thereof
03/05/2009US20090060901 Detoxification method
03/05/2009US20090060898 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
03/05/2009US20090060881 Gamma secretase inhibitor for treatment of herpesvirus infection
03/05/2009US20090060879 Oral Compositions, Products and Methods Of Use
03/05/2009US20090060875 HCV Vaccines for Chronic HCV Patients
03/05/2009US20090060874 Bicyclic pyrrolidine derivatives
03/05/2009US20090060872 Phosphadiazine hcv polymerase inhibitors v
03/05/2009US20090060871 Administration of agonist-antagonist in opioid-dependent patients
03/05/2009US20090060870 for treatment of virally induced intraepithelial neoplasias of the ano-genital tract, such as human papilloma virus-induced vulvar-, cervical-, vaginal-, penile- and anal intraepithelial neoplasias; measuring or detecting the presence of a CD4+ type 1 T helper (Th1) cell response against an HPV
03/05/2009US20090060867 Phosphadiazine hcv polymerase inhibitors iii and vi
03/05/2009US20090060866 Phosphadiazine hcv polymerase inhibitors i and ii
03/05/2009US20090060865 Mammalian receptor proteins; related reagents and methods
03/05/2009DE202008012465U1 Pflanzliche Zusammensetzung zur Behandlung von Fußpilz Herbal composition for the treatment of athlete's foot
1 ... 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 ... 1798